Publications
10
Citations
203
Est. group size
—
Recurring co-author estimate
Active years
11
Publishing since 2015
Mario Alberto Cano-Vega's work focuses on drug delivery and biopharmaceutics, including how drug formulations dissolve, move through the body, and remain stable. Recent work involves developing modeling tools used to predict and standardize drug behavior for regulatory review, as well as earlier work on nanoparticle-based delivery systems (such as chitosan and alginate nanocapsules) to improve the solubility and stability of compounds like curcumin.
Publication output has been low and irregular over the last decade, with only one or two papers in most years and a few gap years, averaging less than one publication per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory Submissions
Molecular Pharmaceutics · 2025
- Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Molecular Pharmaceutics · 2024
- Development of Chitosan and Alginate Nanocapsules to Increase the Solubility, Permeability and Stability of Curcumin
Journal of Pharmaceutical Innovation · 2018
- Molecular Pharmaceutics×2
- Molecular Therapy×2
- Journal of Pharmaceutical Innovation×1
- iScience×1
- Journal of Pharmaceutical Sciences×1
- Alecia Blaszczak
Medicine · The Ohio State University
- Dharti Shantaram
Medicine · The Ohio State University
- Hao Cheng
Medicine · The Ohio State University
- Jiangjiang Zhu
Medicine · The Ohio State University
- Kristin I. Stanford
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile